AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea
· Delayed Price · Currency is KRW
8,510.00
+60.00 (0.71%)
At close: Dec 5, 2025
AptaBio Therapeutics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 237,590 | 171,234 | 201,805 | 237,483 |
| Market Cap Growth | 27.53% | -15.15% | -15.02% | - |
| Enterprise Value | 226,808 | 146,945 | 152,862 | - |
| Last Close Price | 8510.00 | 6370.00 | 9050.00 | 10650.00 |
| Forward PE | - | 78.10 | 78.10 | 78.10 |
| PS Ratio | 69.05 | 50.95 | 623.11 | 4911.46 |
| PB Ratio | 5.33 | 3.16 | 3.29 | 4.54 |
| P/TBV Ratio | 5.51 | 3.16 | 3.32 | 4.54 |
| EV/Sales Ratio | 65.92 | 43.72 | 471.99 | - |
| Debt / Equity Ratio | 0.20 | 0.14 | 0.23 | 0.01 |
| Asset Turnover | 0.05 | 0.04 | 0.00 | - |
| Quick Ratio | 1.15 | 1.67 | 65.10 | 16.58 |
| Current Ratio | 1.27 | 1.79 | 70.27 | 19.63 |
| Return on Equity (ROE) | -43.23% | -50.84% | -21.21% | - |
| Return on Assets (ROA) | -13.89% | -15.24% | -14.22% | - |
| Return on Capital (ROIC) | -17.97% | -18.90% | -16.50% | - |
| Return on Capital Employed (ROCE) | -34.40% | -35.80% | -18.40% | -17.30% |
| Earnings Yield | -8.51% | -17.16% | -5.98% | -4.45% |
| FCF Yield | -6.59% | -7.24% | -7.65% | -3.32% |
| Buyback Yield / Dilution | -4.30% | -5.58% | -0.05% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.